Novartis | Profitto Lordo Sulle Vendite



Gross Profit On Sales Cambiamento Data
AbbVie USD 9.34B 1.36B 2025-03
Amgen USD 6.17B 624M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Bausch Health Companies USD 1.77B 208M 2025-06
Biogen USD 2.04B 238.8M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 191M 36.19M 2025-06
Drreddys Laboratories INR 49.05B 1.28B 2024-12
Eli Lilly USD 13.11B 2.61B 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
Glaxosmithkline GBP 5.6B 94M 2024-12
J&J USD 14.6B 816M 2025-03
Merck USD 12.99B 224M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Novartis USD 10.24B 313M 2024-12
Pacira USD 125.91M 8.71M 2025-06
Perrigo USD 362.9M 29.4M 2025-06
Pfizer USD 10.88B 248M 2025-06
Prestige Brands USD 140.33M 29.68M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
Sanofi EUR 5.36B 4.71B 2024-12
Supernus Pharmaceuticals USD 127.81M 6.25M 2025-06
Zoetis USD 1.78B 180M 2025-06


Novartis Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.